Status:
COMPLETED
Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Hospital Sao Rafael
Alagoas State University of Health Science , Maceió , Brazil.
Conditions:
Chronic Kidney Disease Requiring Chronic Dialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
End-stage chronic kidney disease is associated with the condition of chronic inflammation. Patients on hemodialysis are known to be predisposed to several factors that predispose to inflammation: dial...
Detailed Description
Randomized open-label cross-over trial to investigate impact of Brazilian green propolis extract on inflammation in hemodialysis patients.
Eligibility Criteria
Inclusion
- Age over 18 years;
- Male or female on hemodialysis for at least 1 month.
Exclusion
- Pregnant Woman;
- Carriers of active neoplasms;
- Patients undergoing kidney transplantation during the study;
- Infection during the study;
- Patients who underwent parathyroidectomy during the study;
- Patient using immunosuppressive drugs;
- Allergy to propolis or any of its components;
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04072341
Start Date
August 1 2019
End Date
January 30 2020
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marcelo Augusto Duarte Silveira
Salvador, Estado de Bahia, Brazil, 41820-340